Free radicals contribute to the reduction in peripheral vascular responses and the maintenance of thermal hyperalgesia in rats with chronic constriction injury

Pain

Volumn 79, Issue 1, 1999, Pages 31-37

  Khalil, Zeinab ^a   Liu, Tao ^a   Helme, Robert D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chronic constriction injury; Free radical activity; Hyperalgesia; Neurogenic vascular response

Indexed keywords

FREE RADICAL; SUBSTANCE P; XANTHINE OXIDASE;

ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERALGESIA; MALE; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; FREE RADICALS; HYPERALGESIA; MALE; PERIPHERAL NERVES; PREGNATRIENES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SUBSTANCE P; SUPEROXIDE DISMUTASE; TEMPERATURE; VASODILATION;

EID: 0032896939     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00143-2     Document Type: Article

References (48)

1. Althaus J.S., Andrus P.K., Williams C.M., von Voigtlander P.F., Cazers A.R., Hall E.D. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F). Mol. Chem. Neuropathol. 20:1993;147-162.
2. Andrews P., Helme R. Tachykinin-induced vasodilatation in rat skin measured with a laser doppler flowmeter: evidence for receptor mediator effects. Regul. Pept. 25:1989;267-275.
3. Angel M.F., Narayanan K., Swartz W.M., Ramasastry S.S., Basford R.E., Kuhns D.B., Futrell J.W. The etiological role of free radicals in human hematoma-induced flap necrosis. Plast. Reconstr. Surg. 77:1986;795-801.
4. Attal, N., Jazat, F., Kayser, V. and Guilbaud, G., Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy, Pain, 41 (1990) 235-251.
5. Barut S., Canbolat A., Bilge T., Aydin Y., Cokneseli B., Kaya U. Lipid peroxidation in experimental spinal cord injury: time-level relatioship. Neurosurg. Rev. 16:1993;53-59.
6. Basile S., Khalil Z., Helme R.D. Skin vascular reactivity to the neuropeptide substance P in rats with peripheral mononeuropathy. Pain. 52:1993;217-222.
7. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
8. Benett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
9. Bredt D., Snyder S.H. Nitric oxide, a novel neural messenger. Neuron. 8:1992;3-11.
10. Chan P.K. Role of oxidants in schemic brain damage. Stroke. 27:1996;1124-1129.
11. Choi Y., Raja S.N., Moore L.C., Tobin J.R. Neuropathic pain in rats is associated with alteres nitric oxide synthase activity in neural tissue. J. Neuro. Sci. 138:1996;14-20.
12. Dawson V.L., Dawson T.M. Nitric oxide neurotoxicity, J. Chem. Neuroanat. 10:1996;179-190.
13. Del Maestro R.F., Thaw H.W., Bjork J., Planker M., Arfors K.E. Free radicals as mediators of tissue injury. Acta Physiol. Scand. Suppl. 492:1980;43-57.
14. Dickenson A.H., Sullivan A.F. Evidence for the role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C-fiber stimulation. Neuropharmacology. 26:1987;1235-1238.
15. Feasby T.E., Hahn A.F., Lovgren D., Wilkie L. Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F). Neuropathol. Appl. Neurobiol. 20:1994;384-391.
16. Fici G.J., Althaus J.S., Hall E.D., von Voigtlander P.F. Protective effects of tirilazad methylate in a cellular model of peroxynitrite toxicity. Res. Commun. Mol. Pathol. Pharmacol. 91:1996;357-371.
17. Fiscus R.R., Gross D.R., Hao H., Wang X., Arden W.A., Maley R.H., Salleym R.K. N-nitro-L-arginine blocks the second phase but not the first phase of endothelium-dependent relaxation induced by SP in isolated rings of pig carotid artery. J. Cardiovasc. Pharmacol. 12:1992;S105-S108.
18. Gether U., Johansen T.E., Schwartz T.W. Chimeric NK1 (substance P)/NK-3(neurokinin B) receptors. J. Biol. Chem. 268:1993;7893-7898.
19. Gryglewski R.J., Palmer R.M.J., Moncado S. Superoxide anions are involved in the break down of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
20. Hall, E.D., Inhibition of lipid peroxidation in central nervous system trauma and ischemia, J. Neurol. Sci., 134 Suppl (1995) 79-83.
21. Hassell N.F., Haley E.C. Jr., Apperson-Hansen C., Alves W.M. Randomized, doubleblind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe. Australia and New Zealand, J. Neurosurg. 84:1996;221-228.
22. Helme R.D., Katz B. Management of chronic pain. Med. J. Aust. 15:1993;478-481.
23. Jackson D.L., Graff C.B., Richardson J.D., Hargreazes K.M. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur. J. Pharmacol. 284:1995;321-325.
24. Khalil Z., Helme R. Sequence of events in substance P -induced plasma extravasation in rat skin. Brain Res. 500:1989;256-262.
25. Khalil, Z. and Helme, R.D., Serotonin modulates SP-induced plasma extravasation and vasodilatation in rat skin by an action through capsaicin-sensitive primary afferent nerves, Brain Res 527 (1990) 292-298.
26. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
27. Knight K., Angel M.F., Lepore D.A., Abbey P.A., Arnold L.I., Gray K.A., Mellow C.G., O'Brien B.M. Secondary ischemia in rabbit skin flaps: the roles played by thromboxane and free radicals. Clin. Sci. Colch. 80:1991;235-240.
28. Laurindo F.R., da Luz P.L., Uint L., Rocha T.F., Jaeger R.G., Lopes E.A. Evidence of superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation. 83:1991;1705-1715.
29. Lembek F., Holzer P. Substance P as a neurogenic mediator of antidromic vasodilator and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch. Pharmacol. 310:1979;175-183.
30. Matsui T., Asano T. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two- hemorrhage' model of beagle dogs. Neurosurgery. 34:1994;1035-1039.
31. 2+ in mammalian neurons. Trends Pharmacol. Sci. 11:1990;254-260.
32. McCord J.M. Oxygen derived free radicals in post ischemic tissue injury. N. Engl. J. Med. 312:1985;159-163.
33. Muir J.J.K., Tynan M., Caldwell R., Ellis E.F. Superoxide dismutase improves posttraumatic cortical blood flow in rats. J. Neurotrauma. 12:1995;179-188.
34. Myers, S.I., Hernandez, R. and Castaneda, A., Oxygen free radicals regulate splanchnic nitric oxide synthesis and blood flow, Cardiovasc. Surg., 3 (1995a) 207-210.
35. Myers, S.I., Hernandez, R. and Castaneda, A., Possible role for oxygen radicals in the regulation of renal nitric oxide synthesis and blood flow, Am. J. Surg., 169 (1995b) 604-608.
36. Nishizuka Y. The family of protein kinase C for signal transduction. J. Am. Med. Assoc. 262:1989;1826-1833.
37. Pieper G.M., Gross G.J. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 255:1988;H825-H833.
38. Ralevic V., Khalil Z., Dusting G., Helme R.D. Nitric oxide and sensory nerves are involved in the vasodilator response to acetylcholine but not CGRP in rat skin microvasculature. Br. J. Pharmacol. 106:1992;650-655.
39. Ralevic V., Khalil Z., Helme R.D., Dusting G.J. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur. J. Pharmacol. 284:1995;231-239.
40. Ress A.M., Babvic S., Angel M.F., Im M.J., Dellon A.L., Manson P.N. Free radical damage in acute nerve compression. Ann. Plast. Surg. 34:1995;388-395.
41. Salter M., Strijbos P.J., Neale S., Duffy C., Follenfant R.L., Garthwaite J. The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience. 73:1996;649-655.
42. Seltzer Z., Dubner R., Shir Y. A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
43. Shibuta S., Mashimoto T., Ohara A., Zhang P., Yoshiya I. Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produce thermal hyperalgesia in rats. Neurosci. Lett. 187:1995;103-106.
44. Tal M. A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy. NeuroReport. 7:1996;1382-1384.
45. Thomas D.A., Ren K., Besse D., Ruda M.A., Dubner R. Application of nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester, on injured nerve attenuates neuropathy-induced thermal hyperalgesia in rats. Neurosci. Lett. 21:1996;124-126.
46. Watkins L.R., Wiertelak E.P., Furness L.E., Maier S.F. Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res. 664:1994;17-24.
47. Wiertelak E.P., Furness L.E., Watkins L.R., Maier S.F. Illness- induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res. 664:1994;9-16.
48. Zhou S., Bonasera L., Carlton S.M. Peripheral administration of NMDA, AMPA or KA results in pain behaviours in rats. NeuroReport. 2:1996;895-900.